Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ICATIBANT vs IDELALISIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ICATIBANT vs IDELALISIB: Safety Overview

Metric ICATIBANT IDELALISIB
Total FAERS Reports 5,363 6,862
Deaths Reported 234 1,548
Death Rate 4.4% 22.6%
Hospitalizations 2,451 2,962
Average Patient Age 46.3 yrs 70.0 yrs
% Female Patients 75.0% 38.4%
FDA Approval Date Aug 14, 2023 Jul 23, 2014
Manufacturer Alembic Pharmaceuticals Inc. Gilead Sciences, Inc.
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription